SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0000950135-01-501776
Filing Date
2001-06-26
Accepted
2001-06-26 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b39792b2e424b2.txt 424B2 141927
  Complete submission text file 0000950135-01-501776.txt   143254
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-51772 | Film No.: 1667743
SIC: 2836 Biological Products, (No Diagnostic Substances)